“Yes We Can – Cure Kidney Disease!” (Hybrid Event)

Prabir Roy-Chaudhury, MD, PhD
Professor of Medicine; Co-Director of the University of North Carolina Kidney Center
University of North Carolina

Dr. Roy-Chaudbury is a Professor of Medicine and the Co-Director of the University of North Carolina Kidney Center. Dr. Roy-Chaudbury’s research focuses on understanding pathobiology of dialysis access stenosis and developing new therapies for patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD). With over 75 clinical trials under his belt, Dr. Roy-Chaudbury and his team have led national research efforts and contributed to groundbreaking studies funded by major institutions such as the NIH and VA.

Dr. Roy-Chaudbury has held significant leadership roles in nephrology organizations such as the American Society of Nephrology and the International Society of Nephrology. He was also the founding Co-Chair of the Kidney Health Initiative, a public-private partnership aimed at advancing kidney-related treatments. Currently, Dr. Roy-Chaudbury serves as President of the American Society of Nephrology and is a member of the FDA’s Cardiorenal Drugs Advisory Committee. He is also the founder and Chief Scientific Officer of Inovasc LLC, which is developing smart magnesium based biodegradable stents for preventing AVF maturation failure.

Join Meeting!

Dr. Roy-Chaudhury’s OBJECTIVES:

• Assess the morbidity, mortality and economic cost associated with kidney diseases globally.
• Document the influx of novel therapies into the kidney disease area.
• Leverage these new therapies to create a World without Kidney Diseases.

Faculty Disclosures

Dr. Roy-Chaudhury’s has indicated that she has the following relevant financial relationships with commercial interests:

• Advisor: WL Gore, Medtronic, Becton Dickinson Humacyte
• Advisor: Astra Zeneca, Alexion, Panoramic Science Boston
• Founder: Inovasc, LLC

Planning Committee Disclosure

Dr. Deshpande has indicated the following relevant financial relationships with commercial interests:

• Advisor – GI Health Foundation

Dr. Weiss has indicated the following relevant financial relationships with commercial interests:

• Advisor – Prizm LLC
  
• Advisor – Fortress Pharmaceuticals

Laura Pinzon has indicated she has no relevant financial relationships with commercial interests.

Target Audience

Primary care physicians.

Accreditation

The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.   Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.”